Salvage Chemotherapy With Cisplatin, Ifosfamide, And Paclitaxel In Metastatic Castration-Resistant Prostate Cancer.
JOURNAL OF CLINICAL ONCOLOGY(2021)
摘要
123Background: Recent developments in the treatment of metastatic castration resistant prostate cancer (mCRPC) lead to a revival of platinum-based chemotherapy demonstrating increased activity in p...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要